PL
CLB icon

Perpetual Ltd’s Core Laboratories CLB Stock Holding History

Perpetual Ltd’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49,625
Closed -$5.03M – 188
2017
Q2 		$5.03M Hold
49,625
– – 0.39% 73
2017
Q1 		$5.67M Hold
49,625
– – 0.56% 54
2016
Q4 		$5.96M Buy
49,625
+9,697
+24% +$1.07M 0.91% 29
2016
Q3 		$4.49M Buy
+39,928
New +$4.6M 0.37% 71

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Perpetual Ltd's CLB Position: Q3 2017 in Review

Perpetual Ltd sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 49,625 shares — an estimated $5.03M sold.

Perpetual Ltd first reported a position in CLB in Q3 2016 and held it in 4 quarters. The position peaked at $5.96M in Q4 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Perpetual Ltd reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Perpetual Ltd sold 49,625 Core Laboratories shares in Q3 2017, an estimated $5.03M.
  • Perpetual Ltd first reported a position in Core Laboratories in Q3 2016 and held it in 4 quarters.
  • Perpetual Ltd's Core Laboratories position peaked at $5.96M in Q4 2016.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Perpetual Ltd's 13F filing for Q3 2017, filed 1 Nov 2017.